EZH2 and neoplasm: Since complete ablation of Ezh2 reduced tumour focality and proliferation (Supplementary Figure 1E–G), animals were killed at an endpoint defined by total tumour volume to confirm that metastatic phenotypes were exclusive of the reduced proliferative capacity of Ezh2-null tumours.